- Home
- CCM vs ESLA Comparison
CCM vs ESLA Comparison
Compare CCM & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- ESLA
- Stock Information
- Founded
- CCM 1997
- ESLA 2021
- Country
- CCM China
- ESLA United States
- Employees
- CCM N/A
- ESLA N/A
- Industry
- CCM Medical/Nursing Services
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCM Health Care
- ESLA Health Care
- Exchange
- CCM Nasdaq
- ESLA Nasdaq
- Market Cap
- CCM 33.3M
- ESLA 35.5M
- IPO Year
- CCM 2009
- ESLA N/A
- Fundamental
- Price
- CCM $5.49
- ESLA $0.94
- Analyst Decision
- CCM
- ESLA Strong Buy
- Analyst Count
- CCM 0
- ESLA 1
- Target Price
- CCM N/A
- ESLA $16.00
- AVG Volume (30 Days)
- CCM 4.4K
- ESLA 521.4K
- Earning Date
- CCM 04-25-2025
- ESLA 08-20-2025
- Dividend Yield
- CCM N/A
- ESLA N/A
- EPS Growth
- CCM N/A
- ESLA N/A
- EPS
- CCM N/A
- ESLA N/A
- Revenue
- CCM $52,603,198.00
- ESLA N/A
- Revenue This Year
- CCM N/A
- ESLA $101.09
- Revenue Next Year
- CCM N/A
- ESLA N/A
- P/E Ratio
- CCM N/A
- ESLA N/A
- Revenue Growth
- CCM N/A
- ESLA N/A
- 52 Week Low
- CCM $3.80
- ESLA $0.63
- 52 Week High
- CCM $10.90
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- CCM 36.56
- ESLA 46.99
- Support Level
- CCM $4.91
- ESLA $0.89
- Resistance Level
- CCM $6.47
- ESLA $1.02
- Average True Range (ATR)
- CCM 0.31
- ESLA 0.09
- MACD
- CCM -0.17
- ESLA -0.00
- Stochastic Oscillator
- CCM 24.68
- ESLA 21.16
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.